Abstract
Objective: The pharmacodynamics and pharmacokinetics of ranitidine were examined in subjects with varying degrees of renal function to determine the effect of this condition on acid-antisecretory activity.
Methods: Subjects with creatinine clearances (CCr) ranging from 0 to 213 ml · min−1 received single 50-mg and 25-mg i.v. doses of ranitidine. This was followed by determination of serum and urine ranitidine concentrations, and continuous gastric pH monitoring for 24 h.
Results: Serum ranitidine concentrations were described by a two-compartment model linked to a sigmoidal Emax model describing gastric pH. Ranitidine renal clearance, ranging from 0 to 1003 ml · min−1, correlated with CPAH (r 2 = 0.707), while non-renal clearance was unaltered. Steady-state volume of distribution decreased by half in severe renal impairment. No changes in the effective concentration at half-maximal response (EC50), maximal response (Emax), or basal response (E0) were observed. Thus, renal elimination of ranitidine declined in parallel with renal function, while sensitivity to the pharmacologic effect (gastric pH elevation) was unaltered. Ranitidine was well tolerated in these renally impaired subjects.
Conclusion: These data indicate that the current recommendation for renal impairment dose reduction (by two-thirds when CCr<50 ml · min−1) might result in under-treating moderately impaired patients, and suggests a less conservative dose reduction (by half when CCr<10 ml · min−1) to avoid therapeutic failure while remaining within the wide margin of safety for this drug.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received: 10 September 1996 / Accepted in revised form: 7 December 1996
Rights and permissions
About this article
Cite this article
Koch, K., Liu, M., Davis, I. et al. Pharmacokinetics and pharmacodynamics of ranitidine in renal impairment. E J Clin Pharmacol 52, 229–234 (1997). https://doi.org/10.1007/s002280050279
Issue Date:
DOI: https://doi.org/10.1007/s002280050279